Global Prescription Drugs Market By Product Type (Brand Drugs, Generic Drug) And By End-Users/Application (Hospital, Clinic) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Prescription Drugs market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Prescription Drugs market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Prescription Drugs industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Prescription Drugs ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Prescription Drugs market.

The following manufacturers are covered in this report:
  • Pfizer
  • Roche
  • Sanofi
  • Johnson & Johnson
  • Merck & Co. (MSD)
  • Novartis
  • AbbVie
  • Gilead Sciences
  • GlaxoSmithKline (GSK)
  • Amgen
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lilly
  • Teva
  • Bayer
  • Novo Nordisk
  • Allergan
  • Takeda
  • Boehringer Ingelheim
  • Takeda

The report estimates on the Prescription Drugs market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Prescription Drugs market report consist of all leading industry players, Prescription Drugs business sections, company profile, revenue supply by Prescription Drugs industry sections, global Prescription Drugs market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Prescription Drugs market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Prescription Drugs market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Prescription Drugs market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Prescription Drugs market.

Report Opportunity: Global Prescription Drugs Market

This report delivers an analytical examination of the Prescription Drugs market summarized in broad sections such as
  1. Prescription Drugs Market Summary
  2. Key Commercial Growths in the Prescription Drugs Industry
  3. Market Dynamics Affecting the Prescription Drugs Industry
  4. Important Market Trends and Future Development Scenario of the Prescription Drugs Market
  5. Prescription Drugs Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Prescription Drugs Industry
  7. Positioning of Main Market Players in the Prescription Drugs Industry
  8. Prescription Drugs Market Revenue and Forecast, by Application, 2018 - 2028
  9. Prescription Drugs Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Prescription Drugs Market Revenue and Forecast, by Geography, 2018 - 2028
Prescription Drugs Market Segmentation:

The report provides detailed examination of the Prescription Drugs market on the basis of various segments such as type, application and end-use industry. The Prescription Drugs market is segmented as follows:

Prescription Drugs Market, by Type:
  • Brand Drugs
  • Generic Drug
Prescription Drugs Market, by Application:
  • Hospital
  • Clinic
  • Other
Geographic Coverage

The report on the Prescription Drugs market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Prescription Drugs Market Revenue and Forecast
  • U.S.
  • Canada
Europe Prescription Drugs Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Prescription Drugs Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Prescription Drugs Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Prescription Drugs Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Prescription Drugs Market Snapshot
          2.1.1. Global Prescription Drugs Market By Type,2019
               2.1.1.1.Brand Drugs
               2.1.1.2.Generic Drug
          2.1.2. Global Prescription Drugs Market By Application,2019
               2.1.2.1.Hospital
               2.1.2.2.Clinic
               2.1.2.3.Other
          2.1.3. Global Prescription Drugs Market By End-use,2019
          2.1.4. Global Prescription Drugs Market By Geography,2019

3. Global Prescription Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Prescription Drugs Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Prescription Drugs Market Size (US$), By Type, 2018 – 2028

5. Global Prescription Drugs Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Prescription Drugs Market Size (US$), By Application, 2018 – 2028

6. Global Prescription Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Prescription Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Prescription Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Prescription Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Prescription Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Prescription Drugs Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Prescription Drugs Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Prescription Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Prescription Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Prescription Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Prescription Drugs Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Prescription Drugs Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Prescription Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Prescription Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Prescription Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Prescription Drugs Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Prescription Drugs Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Prescription Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Prescription Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Prescription Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Prescription Drugs Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Prescription Drugs Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Prescription Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Prescription Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Prescription Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Prescription Drugs Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Prescription Drugs Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Prescription Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Prescription Drugs Providers
        8.4.1 Pfizer
                8.1.1 Business Description
                8.1.2 Pfizer Geographic Operations
                8.1.3 Pfizer Financial Information
                8.1.4 Pfizer Product Positions/Portfolio
                8.1.5 Pfizer Key Developments
        8.4.2 Roche
                8.2.1 Business Description
                8.2.2 Roche Geographic Operations
                8.2.3 Roche Financial Information
                8.2.4 Roche Product Positions/Portfolio
                8.2.5 Roche Key Developments
        8.4.3 Sanofi
                8.3.1 Business Description
                8.3.2 Sanofi Geographic Operations
                8.3.3 Sanofi Financial Information
                8.3.4 Sanofi Product Positions/Portfolio
                8.3.5 Sanofi Key Developments
        8.4.4 Johnson & Johnson
                8.4.1 Business Description
                8.4.2 Johnson & Johnson Geographic Operations
                8.4.3 Johnson & Johnson Financial Information
                8.4.4 Johnson & Johnson Product Positions/Portfolio
                8.4.5 Johnson & Johnson Key Developments
        8.4.5 Merck & Co. (MSD)
                8.5.1 Business Description
                8.5.2 Merck & Co. (MSD) Geographic Operations
                8.5.3 Merck & Co. (MSD) Financial Information
                8.5.4 Merck & Co. (MSD) Product Positions/Portfolio
                8.5.5 Merck & Co. (MSD) Key Developments
        8.4.6 Novartis
                8.6.1 Business Description
                8.6.2 Novartis Geographic Operations
                8.6.3 Novartis Financial Information
                8.6.4 Novartis Product Positions/Portfolio
                8.6.5 Novartis Key Developments
        8.4.7 AbbVie
                8.7.1 Business Description
                8.7.2 AbbVie Geographic Operations
                8.7.3 AbbVie Financial Information
                8.7.4 AbbVie Product Positions/Portfolio
                8.7.5 AbbVie Key Developments
        8.4.8 Gilead Sciences
                8.8.1 Business Description
                8.8.2 Gilead Sciences Geographic Operations
                8.8.3 Gilead Sciences Financial Information
                8.8.4 Gilead Sciences Product Positions/Portfolio
                8.8.5 Gilead Sciences Key Developments
        8.4.9 GlaxoSmithKline (GSK)
                8.9.1 Business Description
                8.9.2 GlaxoSmithKline (GSK) Geographic Operations
                8.9.3 GlaxoSmithKline (GSK) Financial Information
                8.9.4 GlaxoSmithKline (GSK) Product Positions/Portfolio
                8.9.5 GlaxoSmithKline (GSK) Key Developments
        8.4.10 Amgen
                8.10.1 Business Description
                8.10.2 Amgen Geographic Operations
                8.10.3 Amgen Financial Information
                8.10.4 Amgen Product Positions/Portfolio
                8.10.5 Amgen Key Developments
        8.4.11 AstraZeneca
                8.11.1 Business Description
                8.11.2 AstraZeneca Geographic Operations
                8.11.3 AstraZeneca Financial Information
                8.11.4 AstraZeneca Product Positions/Portfolio
                8.11.5 AstraZeneca Key Developments
        8.4.12 Bristol-Myers Squibb
                8.12.1 Business Description
                8.12.2 Bristol-Myers Squibb Geographic Operations
                8.12.3 Bristol-Myers Squibb Financial Information
                8.12.4 Bristol-Myers Squibb Product Positions/Portfolio
                8.12.5 Bristol-Myers Squibb Key Developments
        8.4.13 Eli Lilly
                8.13.1 Business Description
                8.13.2 Eli Lilly Geographic Operations
                8.13.3 Eli Lilly Financial Information
                8.13.4 Eli Lilly Product Positions/Portfolio
                8.13.5 Eli Lilly Key Developments
        8.4.14 Teva
                8.14.1 Business Description
                8.14.2 Teva Geographic Operations
                8.14.3 Teva Financial Information
                8.14.4 Teva Product Positions/Portfolio
                8.14.5 Teva Key Developments
        8.4.15 Bayer
                8.15.1 Business Description
                8.15.2 Bayer Geographic Operations
                8.15.3 Bayer Financial Information
                8.15.4 Bayer Product Positions/Portfolio
                8.15.5 Bayer Key Developments
        8.4.16 Novo Nordisk
                8.16.1 Business Description
                8.16.2 Novo Nordisk Geographic Operations
                8.16.3 Novo Nordisk Financial Information
                8.16.4 Novo Nordisk Product Positions/Portfolio
                8.16.5 Novo Nordisk Key Developments
        8.4.17 Allergan
                8.17.1 Business Description
                8.17.2 Allergan Geographic Operations
                8.17.3 Allergan Financial Information
                8.17.4 Allergan Product Positions/Portfolio
                8.17.5 Allergan Key Developments
        8.4.18 Takeda
                8.18.1 Business Description
                8.18.2 Takeda Geographic Operations
                8.18.3 Takeda Financial Information
                8.18.4 Takeda Product Positions/Portfolio
                8.18.5 Takeda Key Developments
        8.4.19 Boehringer Ingelheim
                8.19.1 Business Description
                8.19.2 Boehringer Ingelheim Geographic Operations
                8.19.3 Boehringer Ingelheim Financial Information
                8.19.4 Boehringer Ingelheim Product Positions/Portfolio
                8.19.5 Boehringer Ingelheim Key Developments
        8.4.20 Takeda
                8.20.1 Business Description
                8.20.2 Takeda Geographic Operations
                8.20.3 Takeda Financial Information
                8.20.4 Takeda Product Positions/Portfolio
                8.20.5 Takeda Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Prescription Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Prescription Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Prescription Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Prescription Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Prescription Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Prescription Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Prescription Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Prescription Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Prescription Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Prescription Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Prescription Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Prescription Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Prescription Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Prescription Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Prescription Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Prescription Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Prescription Drugs: Market Segmentation 
FIG. 2 Global Prescription Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Prescription Drugs Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Prescription Drugs Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Prescription Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Prescription Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Prescription Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Prescription Drugs Providers, 2019
FIG. 11 Global Prescription Drugs Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Prescription Drugs Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Prescription Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Prescription Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Prescription Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Prescription Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Prescription Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Prescription Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Prescription Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1903

1834

OUR CLIENT